A small trial used gene editing to switch off a liver gene and cut harmful blood fats by about half. Here’s how a “one-and-done” cholesterol treatment could work—and how the NHS might use it if larger studies prove safe and effective.
A small trial used gene editing to switch off a liver gene and cut harmful blood fats by about half. Here’s how a “one-and-done” cholesterol treatment could work—and how the NHS might use it if larger studies prove safe and effective.